CJC-1295 w/o DAC 10MG + IPA 10MG (20MG)
$100.00
CJC-1295 (no DAC) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Supplied as a lyophilized powder, it is intended exclusively for in vitro laboratory research and analytical applications. This peptide is commonly used to study peptide stability, receptor interactions, and intracellular signaling mechanisms under controlled experimental conditions.
CJC-1295 (no DAC) is a well-characterized synthetic peptide employed in laboratory research to investigate GHRH receptor dynamics, peptide structure, and mechanistic pathways. Its defined sequence allows precise in vitro evaluation in biochemical and assay-based studies. The lyophilized format ensures reproducibility, stability, and integrity for non-clinical experimental applications.
Research Applications
CJC-1295 (no DAC) is suitable for in vitro studies including:
Analysis of GHRH receptor binding and peptide interaction dynamics
Evaluation of intracellular signaling pathways associated with GHRH analogs
Investigation of peptide stability and degradation under defined conditions
Study of structure-function relationships of synthetic peptide analogs
Analytical profiling and mechanistic research in controlled experimental systems
Storage and Handling
Store lyophilized powder at −20°C
After reconstitution, maintain at 2–8°C and use promptly
Avoid repeated freeze-thaw cycles
Follow aseptic techniques during laboratory handling
Product Specifications
Purity: ≥99% (HPLC Certified)
Appearance: White lyophilized powder
Solubility: Soluble in appropriate laboratory solvents
Compliance Notice
For research use only. Not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse may violate federal, state, or local laws. By purchasing, the buyer confirms use strictly for in vitro research purposes.
